Your browser doesn't support javascript.
loading
Semaphorin 3C exacerbates liver fibrosis.
De Angelis Rigotti, Francesca; Wiedmann, Lena; Hubert, Max Ole; Vacca, Margherita; Hasan, Sana S; Moll, Iris; Carvajal, Silvia; Jiménez, Wladimiro; Starostecka, Maja; Billeter, Adrian T; Müller-Stich, Beat; Wolff, Gretchen; Ekim-Üstünel, Bilgen; Herzig, Stephan; Fandos-Ramo, Cristina; Krätzner, Ralph; Reich, Maria; Keitel-Anselmino, Verena; Heikenwälder, Mathias; Mogler, Carolin; Fischer, Andreas; Rodriguez-Vita, Juan.
Affiliation
  • De Angelis Rigotti F; Vascular Signaling and Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wiedmann L; Tumor-Stroma Communication Laboratory, Centro de Investigación Príncipe Felipe, Valencia, Spain.
  • Hubert MO; Vascular Signaling and Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Vacca M; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • Hasan SS; Vascular Signaling and Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Moll I; European Center for Angioscience (ECAS), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Carvajal S; Vascular Signaling and Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jiménez W; Vascular Signaling and Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Starostecka M; Vascular Signaling and Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Billeter AT; Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Müller-Stich B; Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Wolff G; Department of Biomedicine, Medical and Health Sciences School, University of Barcelona, Barcelona, Spain.
  • Ekim-Üstünel B; Vascular Signaling and Cancer Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Herzig S; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • Fandos-Ramo C; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Krätzner R; Department of General, Visceral and Transplantation Surgery, University of Heidelberg Hospital, Heidelberg, Germany.
  • Reich M; Department of General, Visceral and Transplantation Surgery, University of Heidelberg Hospital, Heidelberg, Germany.
  • Keitel-Anselmino V; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Centre Munich, Neuherberg, Germany.
  • Heikenwälder M; Joint Heidelberg-IDC Translational Diabetes Program, Department of Internal Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
  • Mogler C; German Center for Diabetes Research (DZD), Neuherberg, Germany, and Chair Molecular Metabolic Control, Technical University Munich, Munich, Germany.
  • Fischer A; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Centre Munich, Neuherberg, Germany.
  • Rodriguez-Vita J; Joint Heidelberg-IDC Translational Diabetes Program, Department of Internal Medicine 1, Heidelberg University Hospital, Heidelberg, Germany.
Hepatology ; 78(4): 1092-1105, 2023 10 01.
Article in En | MEDLINE | ID: mdl-37055018

Full text: 1 Database: MEDLINE Main subject: Semaphorins / Hepatic Stellate Cells Limits: Animals / Humans Language: En Journal: Hepatology Year: 2023 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Semaphorins / Hepatic Stellate Cells Limits: Animals / Humans Language: En Journal: Hepatology Year: 2023 Type: Article Affiliation country: Germany